New injection targets psoriatic arthritis pain in small trial
NCT ID NCT06522035
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested the safety of an experimental drug called Allocetra, injected directly into the joint, for people with psoriatic arthritis. Only 5 participants were enrolled. The main goal was to check for side effects, with some initial data on pain relief. The study was terminated early, so results are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTHRITIS, PSORIATIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Carmel Medical Center
Haifa, 3436212, Israel
-
Meir Medical Center
Kfar Saba, 4428164, Israel
-
Rambam Medical Center
Haifa, 3109601, Israel
-
Tel Aviv Sourasky Medical Center - Ichilov
Tel Aviv, 6423906, Israel
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New study to measure drug levels in breast milk of moms on TREMFYA
- New drug shows promise in taming psoriatic arthritis flares
- New study tracks arthritis drug persistence in daily life
- Scientists probe hidden pain pathways in arthritis
- New drug combo shows promise for Tough-to-Treat psoriatic arthritis
- New psoriatic arthritis drug shows promise in Mid-Stage trial